We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKCG
326
BNY Mellon Concentrated Growth ETF
BKCG
$120M
$0 ﹤0.01%
+191,899
New +$5.92M
10 11 12 13
14

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.